Extracorporeal treatment/bridging to transplant

View at publisher Summarise with VIRAT
Authors: Samantha Potter, Timothy Thiruchelvam
Cited by: 0
References: 10

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Extracorporeal membrane oxygenation (ECMO), an advanced form of cardiorespiratory support is used in refractory, but traditionally reversible, cardiovascular or respiratory system failure. Where recovery does not occur, ECMO is converted to longer-term mechanical support, organ transplantation may occur, or the child dies from complications or the underlying disease. The steady increase in paediatric ECMO over the last decade, and a huge expanse in adults means that specialist ECMO centres now have well-established expertise, with treatment pathways and policies, international collaboration and registries. ECMO requires cannulation of large vessels or the heart alongside systemic anticoagulation to allow smooth circulation through the cannula and extracorporeal circuit; complications with bleeding and blood clots may specifically affect the brain, but also other organs. Although ECMO indications are expanding, and it is increasingly considered standard therapy with few absolute contraindications, evidence about long-term outcomes is limited, including morbidity and neuro-developmental outcomes. Multiple ethical questions surround ECMO decision-making: selection criteria, communication, the validity of consent in the face of uncertainty, the concept of medically un-advised therapy—including when to discontinue non-beneficial therapies, organ donation, and resource allocation. A ventricular assist device (VAD) is a temporary or durable mechanical pump often surgically implanted, either used de novo or in transition from ECMO for refractory heart failure to sustain the circulation as a bridge to heart transplant or recovery. Ethical issues surrounding VAD are often conflated with ECMO but are distinct: VADs use is inextricably linked to heart transplant candidacy and donor organ availability. Commencing VAD is often elective allowing more time for debate about appropriateness, use can be prolonged (months) with different but fewer patient-burdens, though resource implications are significant. We explore the ethical issues involved in paediatric ECMO and VAD-bridging to transplant, highlighting optimal decision-making processes and communication with families.

Fields of Study & Subjects

Mechanical Circulatory Support Devices Ethics and Legal Issues in Pediatric Healthcare Transplantation: Methods and Outcomes

Publication details

Journal / source
Oxford University Press eBooks
Pages
113–116
Publication date
26 March 2026
Language
EN
Document type
Book chapter